8 April 2021
COVENTRY BUILDING SOCIETY
£5,000,000,000 Euro Medium Term Note Programme
Publication of Supplementary Prospectus
The following supplementary prospectus has been approved by the Financial Conduct Authority and is available for viewing:
Supplementary Prospectus dated 8 April 2021 to the Base Prospectus dated 9 September 2020, as supplemented by a supplementary prospectus dated 4 March 2021 (as so supplemented, the Base Prospectus) relating to the Coventry Building Society £5,000,000,000 Euro Medium Term Note Programme.
To view the full document, please paste the following relevant URL into the address bar of your browser:
http://www.rns-pdf.londonstockexchange.com/rns/8755U_1-2021-4-8.pdf
A copy of the above supplementary prospectus has been submitted to the National Storage Mechanism and will shortly be available for inspection at:
https://data.fca.org.uk/#/nsm/nationalstoragemechanism
For further information, please contact:
Thomas Crane
General Counsel and Secretary
Coventry Building Society
Telephone: 02476 435506
DISCLAIMER - INTENDED ADDRESSEES
Please note that the information contained in the supplementary prospectus (and the Base Prospectus to which it relates) may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Base Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Base Prospectus and the supplementary prospectus is not addressed. Prior to relying on the information contained in the Base Prospectus and the supplementary prospectus, you must ascertain from the Base Prospectus whether or not you are part of the intended addressees of the information contained therein.
Your right to access this service is conditional upon complying with the above requirement.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.